Drug use evaluation in patients with hepatic impairment

dc.authoridBahçecioğlu, Ömer Faruk/0000-0002-4045-4555
dc.authorwosidBahçecioğlu, Ömer Faruk/AAA-7477-2021
dc.contributor.authorGun, Z. U.
dc.contributor.authorTutus, B.
dc.contributor.authorGok, S.
dc.contributor.authorBahcecioglu, O. F.
dc.date.accessioned2024-08-04T20:57:43Z
dc.date.available2024-08-04T20:57:43Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.description.abstract[Abstract Not Available]en_US
dc.identifier.endpage260en_US
dc.identifier.issn2210-7703
dc.identifier.issn2210-7711
dc.identifier.issue1en_US
dc.identifier.startpage260en_US
dc.identifier.urihttps://hdl.handle.net/11616/102873
dc.identifier.volume42en_US
dc.identifier.wosWOS:000526320100141en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofInternational Journal of Clinical Pharmacyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleDrug use evaluation in patients with hepatic impairmenten_US
dc.typeConference Objecten_US

Dosyalar